ORIGINAL RESEARCH
Accepted on 30 May 2025
Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids
doi 10.3389/fphar.2025.1491582
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Innovative Approaches and Molecular Mechanisms in Cardiovascular Pharmacology
Innovative Approaches and Molecular Mechanisms in Cardiovascular Pharmacology
3,333
Total downloads
13k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 30 May 2025
Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle
doi 10.3389/fphar.2025.1573483
- 197 views
ORIGINAL RESEARCH
Accepted on 29 May 2025
Gastrodin Mitigates Aortic Valve Calcification by Inhibiting Glycolysis and Histone Lactylation Through Interfering with Valve Interstitial Cells
doi 10.3389/fphar.2025.1547716
- 105 views
REVIEW
Published on 30 Apr 2025
Macrophage-driven exosomes regulate the progression of cardiovascular disease
doi 10.3389/fphar.2025.1563800
- 1,082 views
REVIEW
Published on 10 Apr 2025
Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease
doi 10.3389/fphar.2025.1499786
- 779 views
REVIEW
Published on 04 Apr 2025
Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence
doi 10.3389/fphar.2025.1493981
- 1,785 views
ORIGINAL RESEARCH
Published on 02 Apr 2025
LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway
doi 10.3389/fphar.2025.1538059
- 935 views
REVIEW
Published on 02 Apr 2025
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology
doi 10.3389/fphar.2025.1499060
- 605 views
ORIGINAL RESEARCH
Accepted on 05 Mar 2025
Thymidine exerts anti-doxorubicin-induced cardiomyopathy effect through the regulation of the PPAR signaling pathways and ferroptosis pathways
doi 10.3389/fphar.2025.1524167
- 209 views
REVIEW
Published on 28 Feb 2025
Effect of sodium-glucose Co-transporter 2 inhibitors on coronary microcirculation
doi 10.3389/fphar.2025.1523727
- 855 views
ORIGINAL RESEARCH
Published on 27 Nov 2024
Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway
doi 10.3389/fphar.2024.1499542
- 1,207 views
ORIGINAL RESEARCH
Published on 10 Apr 2023
Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
doi 10.3389/fphar.2023.1158222
- 2,421 views
- 9 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.